ORPHA:852
X-linked isolated thrombocytopenia with normal platelets size
Publications
12,751,809
Trials
0
Interventional, condition-specific
Researchers
1,477
Distinct authors in sample
Gene link
WAS
Strong
Readiness
4/6
Stages with a signal
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0010743
- MeSH:C564052
- OMIM:313900
- UMLS:C1839163
- NCIT:C176617
Additional Mondo synonyms (5)
X-linked thrombocytopenia with normal platelets · thrombocytopenia 1 · thrombocytopenia type 1 · thrombocytopenia, X-linked, X-linked recessive · thrombocytopenia, X-linked, intermittent, X-linked recessive
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedPresent
Strong — WAS
- LiteraturePresent
12,751,809 matched papers (7,213,593 in last 10 years) Source
- Phenotype characterisedPresent
11 HPO annotations (e.g. Congenital thrombocytopenia; Intermittent thrombocytopenia; Decreased mean platelet volume) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPartial
None under the specific name; 624 for broader category thrombocytopenia
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (WAS).
GenCC classification: Strong.
Phenotypes (Monarch / HPO)
11
Associated phenotypes · MONDO:0010743
- Congenital thrombocytopenia
- Intermittent thrombocytopenia
- Decreased mean platelet volume
- Increased circulating IgE concentration
- Abnormality of the musculature
Showing 5 of 11 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
12,751,809
12,751,809 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
12,751,809 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
7,213,593 in the last 10 years · low confidence
Phrase hits: 3,975 · MeSH hits: 0
Who's working on it?
1,477
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Chen Y5 papers · 2026
Department of Pediatric Gastroenterology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110004, China.
Papers in Europe PMC - 02Li J5 papers · 2026
Department of Thoracic Surgery and Esophageal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Papers in Europe PMC - 03Wang J4 papers · 2026
Department of Neurology, Headache Center, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Papers in Europe PMC - 04Chen L3 papers · 2026
Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Papers in Europe PMC - 05Chen X3 papers · 2026
Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Papers in Europe PMC - 06Fu S3 papers · 2026
Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Papers in Europe PMC - 07Li M3 papers · 2025
Department of Hepatobiliary Oncology, Liver Cancer Institute, National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Papers in Europe PMC - 08Liu Y3 papers · 2026
Department of Geriatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China.
Papers in Europe PMC - 09Piha-Paul SA3 papers · 2026
Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Papers in Europe PMC - 10Shen Y3 papers · 2025
Wuxi Mental Health Center of Nanjing Medical University, Wuxi, Jiangsu, 214151, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 624 trials are registered for thrombocytopenia, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
low confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
624 interventional trials matched thrombocytopenia, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: thrombocytopenia
624
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07206758·RECRUITING·Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia
Conditions: Immune Thrombocytopenia·Matched via name phrase
- NCT07492693·RECRUITING·Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors
Conditions: Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors·Matched via name phrase
- NCT07101627·NOT YET RECRUITING·A Prospective, Multicenter Clinical Study of Hetrombopag in the Prevention of Thrombocytopenia Caused by Lung Cancer Therapy
Conditions: Lung Cancer·Matched via name phrase
- NCT07212322·NOT YET RECRUITING·A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases
Conditions: Systemic Lupus Erythematosus · Idiopahic Inflammatory Myopathies · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis · Sjögren's Syndrome·Matched via name phrase
- NCT06676904·RECRUITING·Neonatal Platelet Transfusion Threshold Trial
Conditions: Thrombocytopenia · Neonatal · Platelet Transfusion · Infant, Newborn, Diseases·Matched via name phrase
- NCT04890041·RECRUITING·TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years
Conditions: Primary Immune Thrombocytopenic Purpura·Matched via name phrase
- NCT07687134·NOT YET RECRUITING·Eltrombopag Plus Telitacicept vs. Eltrombopag Alone for Steroid-refractory/Relapsed ITP
Conditions: Immune Thrombocytopenia·Matched via name phrase
- NCT07315087·RECRUITING·CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases
Conditions: SLE - Systemic Lupus Erythematosus · SSc-Systemic Sclerosis · IIM- Idiopathic Inflammatory Myopathies · ANCA Associated Vasculitis (AAV)·Matched via name phrase
- NCT06371417·RECRUITING·Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Conditions: Antiphospholipid Syndrome (APS) · Bullous Pemphigoid (BP) · Behçet's Syndrome (BS) · Dermatomyositis (DM)·Matched via name phrase
- NCT05214391·RECRUITING·A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia
Conditions: Immune Thrombocytopenia · Treatment·Matched via name phrase
- NCT06913374·NOT YET RECRUITING·The Study of Different Cycles of High-dose Dexamethasone in the Treatment of ITP
Conditions: Thrombocytopenia·Matched via name phrase
- NCT07441720·RECRUITING·Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)
Conditions: Thrombocytopenia · Cancer Treatment-induced Thrombocytopenia·Matched via name phrase
- NCT07362238·RECRUITING·Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)
Conditions: Immune Thrombocytopenia · Treatment·Matched via name phrase
- NCT06787989·RECRUITING·BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases
Conditions: Refractory Immune Cytopenia·Matched via name phrase
- NCT07174843·RECRUITING·An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases
Conditions: Idiopathic Inflammatory Myopathies(IIM) · Immune Thrombocytopenia(ITP) · Systemic Lupus Erythematosus(SLE)·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 40 · after dedupe 40 · already on CT.gov 1 · kept 0 · parent 0 · uncertain 39 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (39)
- isrctn·ISRCTN72157798·Recruiting·Developing a vaccine against Bundibugyo ebolavirus
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN98606172·Recruiting·Personalising treatment for myeloma patients based on initial response to NHS treatment and their overall fitness level
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN70717445·Recruiting·A clinical trial testing vaccines designed to prevent lung cancer in people at risk of recurrent or new lung cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN33436648·Recruiting·The study aims to investigate the effect of the level of probiotic K12 content on enhancing children's immunity and reducing the frequency of their occurrence of diseases such as pharyngitis, tonsillitis, and rhinitis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14753723·Recruiting·A study to test the safety, tolerability and effect of ZI-MA4-1 for patients with locally advanced or metastatic solid malignancies
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14636207·Recruiting·Sonodynamic therapy using focused ultrasound in glioblastomas
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16472226·Recruiting·Study to test the safety and effectiveness of sutacimig for people with a rare bleeding condition called congenital factor VII deficiency
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN41823570·Recruiting·A trial to assess if aspirin with omega-3 and colchicine are medicines that can help recovery from a COPD exacerbation.
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14695157·Recruiting·A study to test the safety of INCB160058 in participants with blood cancers
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN52835444·Not yet recruiting·Using eye blood vessel scans to help predict high blood pressure and poor baby growth in pregnancy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11016599·No longer recruiting·Study of the effect of bridge symptom intervention in symptom management of colorectal cancer patients undergoing postoperative chemotherapy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13575129·Recruiting·Study to test the non-inferiority of the inactivated trivalent influenza vaccine adjuvanted with IB160 from Instituto Butantan compared to a high-dose inactivated trivalent influenza vaccine in adults aged 60 years and older
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN90362708·Recruiting·Bleximenib absorption, metabolism, and excretion in participants with acute leukemia
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN82171427·Recruiting·Testing gabapentin to treat distorted senses of smell after a viral infection
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN90309905·Recruiting·ViTaL02: A study of a new vaccine against Lassa
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17864800·Recruiting·A new treatment for advanced retinoblastoma in Africa
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN62461807·No longer recruiting·A study of a vaccine against Nipah Virus in adults aged 18 to 55 years in Bangladesh
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN84894190·No longer recruiting·Immune imbalance in pediatric persistent immune thrombocytopenia
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12573451·Recruiting·Comparing two ways to remove blood clots from the lungs: how different catheter sizes affect heart recovery and patient outcomes in serious pulmonary embolism
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN73363779·No longer recruiting·Effect of pulmonary rehabilitation on clinical outcomes in patients with lung cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN68248063·Recruiting·Trial of mycophenolate for persistent symptoms of hypothyroidism
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN20573724·Recruiting·A study to assess the safety and efficacy of an experimental malaria vaccine by infecting vaccinated and unvaccinated volunteers with malaria parasites
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16084957·No longer recruiting·VITAL01: A study of a new vaccine against Lassa fever in adults aged 18-55 years
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15110009·No longer recruiting·Using genetic testing to personalize heart treatment for patients undergoing stent procedures in Qatar
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN84570528·Recruiting·Nimodipine for acute optic neuritis
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for X-linked isolated thrombocytopenia with normal platelets size — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("X-linked isolated thrombocytopenia with normal platelets size" OR "X-linked thrombocytopenia with normal platelets" OR "thrombocytopenia 1" OR "thrombocytopenia type 1" OR "thrombocytopenia, X-linked, X-linked recessive" OR "thrombocytopenia, X-linked, intermittent, X-linked recessive") OR ("WAS syndrome" OR "WAS-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"X-linked isolated thrombocytopenia with normal platelets size" OR "X-linked thrombocytopenia with normal platelets" OR "thrombocytopenia 1" OR "thrombocytopenia type 1" OR "thrombocytopenia, X-linked, X-linked recessive" OR "thrombocytopenia, X-linked, intermittent, X-linked recessive"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"thrombocytopenia"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (12751809) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-26T15:39:15.535Z
